Lilly Research Laboratories, et al.; FDA Withdraws Approval of 12 New Drug Applications, 8 Abbreviated Antibiotic Applications, and 23 Abbiated New Drug Applications

Summary

The US Food and Drug Administration (FDA) has withdrawn approval of 12 new drug applications, 8 abbreviated antibiotic applications, and 23 abbreviated new drug applications, following notifications from the applicants that the corresponding drug products are no longer commercially available.